Rezar, R.; Jirak, P.; Gschwandtner, M.; Derler, R.; Felder, T.K.; Haslinger, M.; Kopp, K.; Seelmaier, C.; Granitz, C.; Hoppe, U.C.;
et al. Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far? J. Clin. Med. 2020, 9, 164.
https://doi.org/10.3390/jcm9010164
AMA Style
Rezar R, Jirak P, Gschwandtner M, Derler R, Felder TK, Haslinger M, Kopp K, Seelmaier C, Granitz C, Hoppe UC,
et al. Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far? Journal of Clinical Medicine. 2020; 9(1):164.
https://doi.org/10.3390/jcm9010164
Chicago/Turabian Style
Rezar, Richard, Peter Jirak, Martha Gschwandtner, Rupert Derler, Thomas K. Felder, Michael Haslinger, Kristen Kopp, Clemens Seelmaier, Christina Granitz, Uta C. Hoppe,
and et al. 2020. "Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?" Journal of Clinical Medicine 9, no. 1: 164.
https://doi.org/10.3390/jcm9010164
APA Style
Rezar, R., Jirak, P., Gschwandtner, M., Derler, R., Felder, T. K., Haslinger, M., Kopp, K., Seelmaier, C., Granitz, C., Hoppe, U. C., & Lichtenauer, M.
(2020). Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far? Journal of Clinical Medicine, 9(1), 164.
https://doi.org/10.3390/jcm9010164